|
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC |
|
|
|
Title: |
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC |
Author: |
Takeyasu, Yuki Yoshida, Tatsuya Shibaki, Ryota Matsumoto, Yuji Goto, Yasushi Kanda, Shintaro Horinouchi, Hidehito Yamamoto, Noboru Motoi, Noriko Ohe, Yuichiro |
Appeared in: |
Clinical lung cancer |
Paging: |
Volume 22 () nr. 2 pages 127-133.e3 |
Year: |
2021 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|